Study Proves iTind Treatment for Enlarged Prostate Lasts More than Four Years

Due to the COVID-19 pandemic, patients could not be examined in-person for functional testing at the >48-month follow-up. Hence, the protocol was adapted so that data regarding long-term symptoms' relief, (IPSS), QoL improvement and the need for re-treatment could be gathered telephonically. Due to the COVID-19 pandemic, patients could not be examined in-person for functional testing at the >48-month follow-up. Hence, the protocol was adapted so that data regarding long-term symptoms'...

Due to the COVID-19 pandemic, patients could not be examined in-person for functional testing at the >48-month follow-up. Hence, the protocol was adapted so that data regarding long-term symptoms' relief, (IPSS), QoL improvement and the need for re-treatment could be gathered telephonically.

Summary of Long-term Study Results

The study was funded by Medi-Tate, a wholly owned subsidiary of Olympus Corporation.

To read the full press release, visit: www.olympus-europa.com

About Olympus

For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit www.olympus-europa.com.

 

Photo - https://mma.prnewswire.com/media/2152729/Olympus_Corporation_itind_threesteps.jpg 
Logo - https://mma.prnewswire.com/media/1774929/4160711/Olympus_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/study-proves-itind-treatment-for-enlarged-prostate-lasts-more-than-four-years-301876989.html